RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
G
Abcb1a
ATP binding cassette subfamily B member 1A
susceptibility
ISO
RGD
PMID:15505619
RGD:1598568
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
G
Acsm3
acyl-CoA synthetase medium-chain family member 3
ISO
mRNA:decreased expression:colonic mucosa
RGD
PMID:21987487
RGD:7241281
NCBI chr 1:174,133,260...174,159,966
Ensembl chr 1:174,133,288...174,160,184
G
Adcy7
adenylate cyclase 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28067910
NCBI chr19:18,740,875...18,798,924
Ensembl chr19:18,740,875...18,776,311
G
Adipoq
adiponectin, C1Q and collagen domain containing
ISO
protein:increased expression:serum
RGD
PMID:16432373
RGD:5686726
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
G
Adrb2
adrenoceptor beta 2
IEP
protein:decreased expression:large intestine mucosa,spleen
RGD
PMID:22772914
RGD:7175063
NCBI chr18:55,642,459...55,644,501
Ensembl chr18:55,502,903...55,644,512
G
Alb
albumin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35999755
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
G
Alox12
arachidonate 12-lipoxygenase, 12S type
ISO
protein:increased expression:large intestine epithelium
RGD
PMID:7679252
RGD:5509621
NCBI chr10:54,958,263...54,970,542
Ensembl chr10:54,958,271...54,970,542
G
Alpi
alkaline phosphatase, intestinal
ISO
protein:decreased expression:colonic mucosa
RGD
PMID:22783049
RGD:14367879
NCBI chr 9:87,773,411...87,776,877
Ensembl chr 9:87,773,411...87,776,877
G
Apln
apelin
ISO
protein:increased expression:intestine
RGD
PMID:17391779
RGD:1626177
NCBI chr X:127,180,801...127,213,567
Ensembl chr X:127,203,823...127,213,391
G
Apoa4
apolipoprotein A4
severity
ISO
DNA:missense mutation:cds:p.Q360H (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:35999755 PMID:17206692
RGD:5685660
NCBI chr 8:46,539,083...46,541,464
Ensembl chr 8:46,539,082...46,541,469
G
Aqp7
aquaporin 7
severity
ISO
mRNA, protein:decreased expression:colon
RGD
PMID:15338270
RGD:1626292
NCBI chr 5:56,171,649...56,186,642
Ensembl chr 5:56,172,519...56,186,642
G
Arpc2
actin related protein 2/3 complex, subunit 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18836448
NCBI chr 9:75,820,782...75,851,471
Ensembl chr 9:75,820,770...75,851,471
G
Brinp3
BMP/retinoic acid inducible neural specific 3
ISO
mRNA,protein:decreased expression:intestine
RGD
PMID:25171508
RGD:14398484
NCBI chr13:58,413,883...58,846,828
Ensembl chr13:58,413,883...58,846,770
G
Btnl2
butyrophilin-like 2
susceptibility
ISO
DNA:SNPs: : rs2294881,rs9268480,rs2076523(human)
RGD
PMID:19659809
RGD:9685032
NCBI chr20:4,490,169...4,504,002
Ensembl chr20:4,489,517...4,503,341
G
C3
complement C3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35999755
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
G
Card9
caspase recruitment domain family, member 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20228799
NCBI chr 3:9,171,814...9,180,310
Ensembl chr 3:9,171,815...9,180,237
G
Casp3
caspase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24055189
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Ccl20
C-C motif chemokine ligand 20
treatment
IEP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16306769 PMID:21887805
RGD:7488892
NCBI chr 9:84,389,031...84,391,629
Ensembl chr 9:84,388,904...84,391,629
G
Ccl7
C-C motif chemokine ligand 7
ISO
protein:increased expression:colon
RGD
PMID:10433925
RGD:6483784
NCBI chr10:67,016,446...67,018,296
Ensembl chr10:67,016,446...67,018,303
G
Ccny
cyclin Y
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18438405
NCBI chr17:57,385,002...57,512,860
Ensembl chr17:57,384,176...57,522,378
G
Ccr3
C-C motif chemokine receptor 3
ISO
RGD
PMID:21077277
RGD:6892920
NCBI chr 8:123,586,100...123,634,178
Ensembl chr 8:123,616,236...123,634,990
G
Ccr6
C-C motif chemokine receptor 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16306769
NCBI chr 1:52,474,477...52,508,301
Ensembl chr 1:52,474,168...52,498,603
G
Cd40
CD40 molecule
ISO
protein:increased expression:intestine, epithelial cell
RGD
PMID:20133813
RGD:5490590
NCBI chr 3:153,790,372...153,805,279
Ensembl chr 3:153,790,449...153,805,534
G
Cdh1
cadherin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19915572
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
G
Cdh3
cadherin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19915572
NCBI chr19:34,393,596...34,444,084
Ensembl chr19:34,393,727...34,444,084
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
disease_progression
ISO
RGD
PMID:15743319
RGD:8662406
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
G
Cfb
complement factor B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35999755
NCBI chr20:3,970,643...3,976,510
Ensembl chr20:3,951,474...3,976,505
G
Chrna7
cholinergic receptor nicotinic alpha 7 subunit
ISO
mRNA:increased expression:intestine:
RGD
PMID:27051591
RGD:151667910
NCBI chr 1:116,711,559...116,837,269
Ensembl chr 1:116,714,711...116,837,240
G
Col18a1
collagen type XVIII alpha 1 chain
IEP
Protein:increased expression:large intestine mucosa
RGD
PMID:17011522
RGD:1600887
NCBI chr20:11,474,104...11,582,593
Ensembl chr20:11,474,104...11,582,593
G
Col1a1
collagen type I alpha 1 chain
ISO
RGD
PMID:17939044
RGD:5688304
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
G
Col6a3
collagen type VI alpha 3 chain
ISO
protein:increased expression:serum (human)
RGD
PMID:32245981
RGD:401900121
NCBI chr 9:91,361,578...91,439,434
Ensembl chr 9:91,361,583...91,439,471
G
Cxcr1
C-X-C motif chemokine receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21297633
NCBI chr 9:75,766,894...75,771,079
Ensembl chr 9:75,766,770...75,771,084
G
Cxcr2
C-X-C motif chemokine receptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21297633
NCBI chr 9:75,729,493...75,735,868
Ensembl chr 9:75,729,115...75,739,425
G
Cxcr3
C-X-C motif chemokine receptor 3
ISO
mRNA:increased expression:peripheral blood immature plasma cells (human)
RGD
PMID:21087446
RGD:6480657
NCBI chr X:66,844,318...66,846,969
Ensembl chr X:66,844,318...66,846,969
G
Cxcr4
C-X-C motif chemokine receptor 4
ISO
mRNA:increased expression:peripheral blood immature plasma cells (human)
RGD
PMID:21087446
RGD:6480657
NCBI chr13:40,077,976...40,081,883
Ensembl chr13:40,077,976...40,081,883
G
Cyp24a1
cytochrome P450, family 24, subfamily a, polypeptide 1
susceptibility
ISO
DNA:SNPs:multiple (human)
RGD
PMID:28811712
RGD:151665177
NCBI chr 3:159,275,947...159,290,383
Ensembl chr 3:159,275,947...159,290,383
G
Dap
death-associated protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21297633
NCBI chr 2:82,199,206...82,251,771
Ensembl chr 2:82,199,280...82,251,752
G
Defa5
defensin alpha 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20452301
NCBI chr16:70,342,530...70,344,854
Ensembl chr16:70,342,530...70,344,836
G
Dpep1
dipeptidase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35999755
NCBI chr19:51,209,831...51,237,004
Ensembl chr19:51,219,660...51,235,257
G
Duox2
dual oxidase 2
ISO
mRNA:increased expression:colon (human)
RGD
PMID:19759286
RGD:40924645
NCBI chr 3:109,223,809...109,247,023
Ensembl chr 3:109,226,924...109,245,902
G
Ecm1
extracellular matrix protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18438406
NCBI chr 2:183,287,491...183,292,729
Ensembl chr 2:183,287,322...183,292,671
G
Ephb2
Eph receptor B2
ameliorates
IDA
RGD
PMID:33722292
RGD:127285641
NCBI chr 5:148,889,574...149,077,027
Ensembl chr 5:148,897,246...149,077,059
G
Esr2
estrogen receptor 2
ISO
mRNA:decreased expression:colon
RGD
PMID:21252046
RGD:5508810
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
G
F2
coagulation factor II, thrombin
ISO
RGD
PMID:21593018
RGD:5147754
NCBI chr 3:77,596,196...77,609,486
Ensembl chr 3:77,596,198...77,609,486
G
Fas
Fas cell surface death receptor
treatment
IEP
RGD
PMID:30122878
RGD:13792562
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
G
Faslg
Fas ligand
treatment
IEP
RGD
PMID:30122878
RGD:13792562
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
G
Fcgr2a
Fc gamma receptor 2A
susceptibility
ISO
DNA:polymorphism: :p.A519G (human) CTD Direct Evidence: marker/mechanism DNA:SNP: :rs1801274 (human)
CTD RGD
PMID:19915573 PMID:20228799 PMID:20848524 PMID:19915573
RGD:5147918 , RGD:5147922
NCBI chr13:83,280,782...83,297,535
Ensembl chr13:83,280,784...83,295,967
G
Fgf7
fibroblast growth factor 7
ISO
mRNA:increased expression:colon, lamina propria, myofibroblasts (human)
RGD
PMID:9358773
RGD:126928145
NCBI chr 3:113,280,448...113,333,279
Ensembl chr 3:113,281,283...113,332,929
G
Gc
GC, vitamin D binding protein
susceptibility
ISO
DNA:polymorphism:cds:p.T420K(human)
RGD
PMID:21832969
RGD:5509866
NCBI chr14:18,632,146...18,667,563
Ensembl chr14:18,632,135...18,667,567
G
Ghrl
ghrelin and obestatin prepropeptide
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19617644
NCBI chr 4:146,865,712...146,869,621
Ensembl chr 4:146,865,712...146,869,621
G
Gna12
G protein subunit alpha 12
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21297633
NCBI chr12:13,805,580...13,886,255
Ensembl chr12:13,805,698...13,886,255
G
Gpr65
G-protein coupled receptor 65
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30616622
NCBI chr 6:117,515,786...117,536,514
Ensembl chr 6:117,515,648...117,536,512
G
Gpx1
glutathione peroxidase 1
ISO
protein:decreased expression:erythrocyte
RGD
PMID:20186929
RGD:11352754
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
G
Gpx2
glutathione peroxidase 2
disease_progression
ISO
protein:increased expression:large intestine (human)
RGD
PMID:18479189
RGD:152998902
NCBI chr 6:95,493,589...95,496,877
Ensembl chr 6:95,493,589...95,496,877
G
Gstm1
glutathione S-transferase mu 1
susceptibility
ISO
DNA:deletion: :
RGD
PMID:17565649 PMID:28626742 PMID:26604430
RGD:5490554 , RGD:14700999 , RGD:11538341
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
G
Gstt1
glutathione S-transferase theta 1
susceptibility
ISO
DNA:deletion: :
RGD
PMID:17565649 PMID:26604430
RGD:5490554 , RGD:11538341
NCBI chr20:12,856,613...12,873,586
Ensembl chr20:12,856,669...12,873,585
G
Herc2
HECT and RLD domain containing E3 ubiquitin protein ligase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18438405
NCBI chr 1:106,904,789...107,110,997
Ensembl chr 1:106,880,084...107,108,134
G
Hnf4a
hepatocyte nuclear factor 4, alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19915572
NCBI chr 3:152,186,787...152,248,320
Ensembl chr 3:152,186,787...152,248,320
G
Hnmt
histamine N-methyltransferase
ISO
RGD
PMID:18340362
RGD:5509777
NCBI chr 3:6,591,804...6,623,821
Ensembl chr 3:6,591,463...6,624,012
G
Hp
haptoglobin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35999755
NCBI chr19:37,539,626...37,544,178
Ensembl chr19:37,539,627...37,544,523
G
Hspa4
heat shock protein family A (Hsp70) member 4
ISO
protein:increased expression:colon mucosa, epithelium (human)
RGD
PMID:22297444
RGD:5688753
NCBI chr10:37,408,025...37,449,080
Ensembl chr10:37,408,025...37,449,001
G
Htra1
HtrA serine peptidase 1
ISO
protein:decreased expression:colonic epithelium,colonic mucosa (human)
RGD
PMID:28586045
RGD:152985530
NCBI chr 1:185,497,815...185,547,380
Ensembl chr 1:185,497,735...185,547,379
G
Icam1
intercellular adhesion molecule 1
IEP ISO
mRNA:increased expression:substantia nigra (rat) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:15553846 PMID:20584104
RGD:4145388
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
G
Icoslg
inducible T-cell co-stimulator ligand
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20228799
NCBI chr20:10,600,420...10,610,718
Ensembl chr20:10,600,420...10,610,703
G
Igf1r
insulin-like growth factor 1 receptor
ISO
protein:altered expression:colon
RGD
PMID:18938767
RGD:5686432
NCBI chr 1:121,549,831...121,838,548
Ensembl chr 1:121,550,743...121,831,777
G
Igf2
insulin-like growth factor 2
disease_progression
ISO
RGD
PMID:16088202
RGD:5509966
NCBI chr 1:197,814,409...197,831,802
Ensembl chr 1:197,814,410...197,823,018
G
Ikzf1
IKAROS family zinc finger 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20228799
NCBI chr14:86,255,065...86,340,839
Ensembl chr14:86,255,065...86,342,416
G
Il10
interleukin 10
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:18836448 PMID:20228799 PMID:26660358 PMID:28120341
RGD:14975255 , RGD:14975153
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Il12b
interleukin 12B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18438406 PMID:20228799 PMID:21297633
NCBI chr10:28,888,832...28,903,802
Ensembl chr10:28,893,008...28,902,903
G
Il18rap
interleukin 18 receptor accessory protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20228799
NCBI chr 9:42,768,112...42,800,964
Ensembl chr 9:42,768,220...42,800,959
G
Il1b
interleukin 1 beta
IEP ISO
protein:increased expression:lung CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:12133438 PMID:15955209 PMID:20452301 PMID:22119283 PMID:24812904
RGD:10450593
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il1r2
interleukin 1 receptor type 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21297633
NCBI chr 9:42,384,280...42,424,726
Ensembl chr 9:42,384,433...42,424,725
G
Il1rn
interleukin 1 receptor antagonist
ISO
DNA:repeats:intron:IVS2+914_1000dup IL1RN*2 (human)
RGD
PMID:8119534
RGD:6909136
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
G
Il23r
interleukin 23 receptor
ISO
DNA:SNP,Haplotype: :rs1884444(human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:18438406 PMID:19122664 PMID:20228799 PMID:23093364
RGD:8549574
NCBI chr 4:96,580,568...96,672,540
Ensembl chr 4:96,580,714...96,674,021
G
Il33
interleukin 33
severity treatment
ISO
mRNA:increased expression:sigmoid colon
RGD
PMID:25112700 PMID:21037074 PMID:28802904
RGD:39938951 , RGD:40813742 , RGD:39938966
NCBI chr 1:227,701,964...227,736,374
Ensembl chr 1:227,721,435...227,736,373
G
Il7r
interleukin 7 receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21297633
NCBI chr 2:58,452,393...58,477,757
Ensembl chr 2:58,454,217...58,477,757
G
Irf5
interferon regulatory factor 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21297633
NCBI chr 4:58,127,577...58,140,665
Ensembl chr 4:58,127,640...58,139,267
G
Irgm
immunity-related GTPase M
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20228799
NCBI chr10:33,233,513...33,241,594
Ensembl chr10:33,233,455...33,241,578
G
Jak2
Janus kinase 2
ISO
DNA:SNP: :rs10758669 (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:20228799 PMID:21297633 PMID:22269120
RGD:6483020
NCBI chr 1:226,995,334...227,054,381
Ensembl chr 1:226,995,334...227,054,189
G
Kdr
kinase insert domain receptor
ISO
protein:increased expression:colon
RGD
PMID:19013462
RGD:5684406
NCBI chr14:32,217,871...32,261,018
Ensembl chr14:32,217,871...32,261,018
G
Kif21b
kinesin family member 21B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20228799
NCBI chr13:47,576,129...47,626,112
Ensembl chr13:47,576,160...47,626,127
G
Lamb1
laminin subunit beta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19915572
NCBI chr 6:47,835,492...47,902,585
Ensembl chr 6:47,835,525...47,902,585
G
Lsp1
lymphocyte-specific protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21297633
NCBI chr 1:197,614,677...197,648,414
Ensembl chr 1:197,614,687...197,648,416
G
Ltf
lactotransferrin
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:16640825 PMID:35999755
NCBI chr 8:110,999,948...111,022,795
Ensembl chr 8:110,999,948...111,022,795
G
Masp2
MBL associated serine protease 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12904520
NCBI chr 5:159,035,892...159,049,561
Ensembl chr 5:159,035,911...159,049,580
G
Mir155
microRNA 155
ISO
miRNA:increased expression:colon miRNA:decreased expression:feces
RGD
PMID:30927737 PMID:29438285 PMID:29325325 PMID:29668922
RGD:21079443 , RGD:21403682 , RGD:24922207 , RGD:24922213
NCBI chr11:23,774,654...23,774,718
Ensembl chr11:23,774,654...23,774,718
G
Mir31
microRNA 31
ISO
miRNA:increased expression:colon
RGD
PMID:29438285
RGD:21403682
NCBI chr 5:103,599,038...103,599,143
G
Mmp1
matrix metallopeptidase 1
IDA
RGD
PMID:18837084
RGD:7207395
NCBI chr 8:4,658,588...4,679,099
Ensembl chr 8:4,658,588...4,679,097
G
Mmp9
matrix metallopeptidase 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22119283
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
Mpo
myeloperoxidase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20380826 PMID:22119283 PMID:24055189
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
G
Mst1
macrophage stimulating 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18438406 PMID:20228799
NCBI chr 8:108,767,886...108,773,425
Ensembl chr 8:108,768,839...108,773,416
G
Mtrr
5-methyltetrahydrofolate-homocysteine methyltransferase reductase
susceptibility
ISO
DNA:polymorphism: :66A>G (human)
RGD
PMID:21947961
RGD:5508217
NCBI chr 1:34,866,991...34,899,425
Ensembl chr 1:34,867,089...34,899,425
G
Muc2
mucin 2, oligomeric mucus/gel-forming
IEP
mRNA:altered expression: :
RGD
PMID:12870797
RGD:2324685
NCBI chr 1:196,799,494...196,831,740
Ensembl chr 1:196,799,517...196,831,756
G
Nkx2-3
NK2 homeobox 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18438405 PMID:18438406 PMID:20228799
NCBI chr 1:242,478,130...242,481,083
Ensembl chr 1:242,478,130...242,481,083
G
Nod2
nucleotide-binding oligomerization domain containing 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20452301
NCBI chr19:18,382,369...18,422,817
Ensembl chr19:18,382,439...18,417,177
G
Ormdl3
ORMDL sphingolipid biosynthesis regulator 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20228799
NCBI chr10:83,590,052...83,596,035
Ensembl chr10:83,590,071...83,598,620
G
Pon1
paraoxonase 1
ISO
mRNA:decreased expression:colon (human)
RGD
PMID:17664137
RGD:5509924
NCBI chr 4:33,294,737...33,325,759
Ensembl chr 4:33,294,722...33,321,360
G
Pon3
paraoxonase 3
ISO
mRNA:decreased expression:colon (human)
RGD
PMID:17664137
RGD:5509924
NCBI chr 4:33,356,983...33,383,681
Ensembl chr 4:33,349,168...33,383,855
G
Prdm1
PR/SET domain 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21297633
NCBI chr20:47,959,858...47,981,488
Ensembl chr20:47,959,858...47,981,488
G
Psmg1
proteasome assembly chaperone 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20228799
NCBI chr11:35,276,080...35,285,541
Ensembl chr11:35,276,011...35,285,622
G
Ptger4
prostaglandin E receptor 4
ISO
RGD
PMID:21818367
RGD:6483532
NCBI chr 2:54,330,563...54,347,451
Ensembl chr 2:54,335,424...54,346,670
G
Ptgs1
prostaglandin-endoperoxide synthase 1
IMP
RGD
PMID:17429720
RGD:2300267
NCBI chr 3:19,584,015...19,605,589
Ensembl chr 3:19,584,015...19,605,586
G
Ptgs2
prostaglandin-endoperoxide synthase 2
IMP
RGD
PMID:17429720
RGD:2300267
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Ptpn2
protein tyrosine phosphatase, non-receptor type 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18438405
NCBI chr18:61,229,012...61,294,662
Ensembl chr18:61,229,014...61,294,627
G
Rela
RELA proto-oncogene, NF-kB subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15955209
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Ripk2
receptor-interacting serine-threonine kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20452301
NCBI chr 5:29,630,806...29,662,804
Ensembl chr 5:29,631,570...29,662,657
G
RT1-Bb
RT1 class II, locus Bb
ISO
RGD
PMID:31038770
RGD:14865009
NCBI chr20:4,596,558...4,602,201
Ensembl chr20:4,596,559...4,607,597
G
RT1-Db1
RT1 class II, locus Db1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25559196
NCBI chr20:4,548,664...4,558,237
Ensembl chr20:4,548,666...4,558,258
G
Sell
selectin L
ISO
DNA:polymorphism: :p.F206L (human)
RGD
PMID:19212205
RGD:13464267
NCBI chr13:76,416,969...76,436,444
Ensembl chr13:76,416,915...76,436,456
G
Selp
selectin P
ISO
protein:increased expression:serum
RGD
PMID:21526498
RGD:6218993
NCBI chr13:76,476,229...76,511,846
Ensembl chr13:76,476,295...76,511,845
G
Slc11a1
solute carrier family 11 member 1
ISO
DNA:transition, repeat:promoter:-237C>T (human) DNA:polymorphism:promoter (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16059695 PMID:18340647 PMID:11929588
RGD:5684939 , RGD:5684968
NCBI chr 9:75,957,193...75,968,115
Ensembl chr 9:75,957,316...75,968,101
G
Slc26a3
solute carrier family 26 member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19915573
NCBI chr 6:48,023,892...48,064,829
Ensembl chr 6:48,023,892...48,064,772
G
Sphk1
sphingosine kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24055189
NCBI chr10:101,758,567...101,764,240
Ensembl chr10:101,758,711...101,764,240
G
Stat3
signal transducer and activator of transcription 3
ISO
DNA:SNP: :rs744166 (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:18438405 PMID:20228799 PMID:22269120
RGD:6483020
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
G
Thbd
thrombomodulin
ISO
protein:decreased expression:colon, blood vessel
RGD
PMID:17557119
RGD:5685011
NCBI chr 3:135,863,366...135,867,018
Ensembl chr 3:135,862,835...135,867,193
G
Tnf
tumor necrosis factor
treatment
ISO IEP
CTD Direct Evidence: marker/mechanism protein:increased expression:lung
CTD RGD
PMID:19617644 PMID:20452301 PMID:22119283 PMID:25204186 PMID:28120341 PMID:24812904 More...
RGD:10450577 , RGD:14975153 , RGD:10450593
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfaip3
TNF alpha induced protein 3
severity
ISO
mRNA,protein:increased expression, decreased expression:colonic mucosa (human)
RGD
PMID:28842689
RGD:151347619
NCBI chr 1:13,709,211...13,724,291
Ensembl chr 1:13,709,206...13,725,282
G
Tnfsf15
TNF superfamily member 15
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20228799
NCBI chr 5:77,134,885...77,156,171
Ensembl chr 5:77,139,878...77,156,228
G
Tp53
tumor protein p53
ISO
GAD
PMID:15118671
RGD:1331525
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Vcam1
vascular cell adhesion molecule 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15553846
NCBI chr 2:204,038,120...204,057,852
Ensembl chr 2:204,038,114...204,057,958
G
Vegfa
vascular endothelial growth factor A
ISO
protein:increased expression:plasma, large intestine mucosa
RGD
PMID:19013462
RGD:5684406
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
G
Vip
vasoactive intestinal peptide
severity
ISO
mRNA:decreased expression:colon
RGD
PMID:22143367
RGD:5685619
NCBI chr 1:42,064,878...42,073,219
Ensembl chr 1:42,065,120...42,073,216
G
Vipr1
vasoactive intestinal peptide receptor 1
ISO
RGD
PMID:17611633
RGD:5685618
NCBI chr 8:121,303,739...121,339,587
Ensembl chr 8:121,310,248...121,339,585
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all